You are here: Industry Insights > Malaria

News List

Novartis invests $100 mn to eliminate malaria europeanpharmaceuticalreview
April 24, 2018
Novartis is to invest more than $ 100 million to advance research and development of new antimalarials over the next five years…
Novartis to Spend $100M on Malaria Initiative biospace
April 18, 2018
One of the nastier viruses carried by mosquitoes, malaria, was responsible for the deaths of more than 445,000 people in 2016.
Improving Malaria Diagnosis Using Artificial Intelligence; VisionQuest Biomedical and Volk Optical P biospace
March 13, 2018
VisionQuest Biomedical LLC has partnered with Volk Optical (Mentor, OH) to develop a technological solution that could potentially save the lives of hundreds of thousands of children under 5 years old in Africa
German researchers propose new medication for malaria biospectrumasia
January 24, 2018
The new combination meets World Health Organization (WHO) guidelines for combination therapies.
Mekong countries call for accelerated action to eliminate malaria before 2030 biospectrumasia
December 11, 2017
The call comes amid concern over resistance of malaria parasites to antimalarial drugs
GSK submits bold US application for tafenoquine, targeting malaria pharmaasia
December 07, 2017
Bold GSK attempt is for the first new medicine targeting P.vivax malaria in 60 years. Tafenoquine is not approved for use anywhere in the world.
Global response to malaria at crossroads: World Malaria Report 2017 biospectrumasia
November 30, 2017
Malaria deaths stood at around 445,000 which is a similar number to the previous year
Breathalyser for malaria shows promise in trials pharmafile
November 08, 2017
Access to sophisticated rapid blood tests for malaria has improved dramatically in recent years but there are still issues in rural settings, meaning this option can be expensive and impractical
New method for producing malaria treatment at large scales europeanpharmaceuticalreview
September 11, 2017
New research demonstrates that the malaria treatment, artemisinin can now be rapidly produced by genetically engineered moss at an industrial scale…
Novartis and Medicines for Malaria Venture launch patient trial in Africa for KAF156, a novel compou worldpharmanews
August 22, 2017
Novartis and Medicines for Malaria Venture (MMV) have launched a patient trial for KAF156, a next-generation antimalarial compound with the potential to treat drug-resistant strains of the malaria parasite.

Previous page 1 2 3 4 5 6 7 Next page